Telerehabilitation for Low Vision
(BeST-AID Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two methods of follow-up care for individuals with low vision using magnification devices: traditional in-office visits and remote telerehabilitation via video calls. The researchers aim to determine if telerehabilitation is equally effective in helping individuals manage daily activities like reading. Additionally, the trial explores the use of Bluetooth sensors to monitor device usage, potentially enhancing support. The study seeks adults who have recently begun using magnifiers or visual assistive apps due to vision loss from any eye condition. As an unphased trial, it offers a unique opportunity to contribute to innovative care methods for low vision.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on vision rehabilitation, so it's best to discuss your medications with the trial coordinators.
What prior data suggests that telerehabilitation for low vision is safe?
Research has shown that telerehabilitation for people with low vision is safe. This method uses video calls to help patients learn to use visual aids at home. Studies have confirmed its safety and effectiveness. For instance, one study used special questionnaires to ensure participants did not experience negative effects, such as feeling sick from the technology. Additionally, thorough vision checks conducted after standard low-vision tests support the treatment's safety. These findings suggest that telerehabilitation is a well-accepted option for those with low vision.12345
Why are researchers excited about this trial?
Unlike the traditional in-office low vision rehabilitation, which involves face-to-face sessions for using magnification or visual assistive devices, telerehabilitation offers a fresh approach by delivering follow-up care remotely via videoconferencing. This method is unique because it provides convenience and accessibility, allowing patients to receive necessary care without the need to travel. Researchers are excited because this could significantly enhance access to care for individuals with low vision, especially those with mobility challenges or living in remote areas. By bridging the gap between patients and providers, telerehabilitation has the potential to make vision rehabilitation more efficient and widespread.
What evidence suggests that telerehabilitation is effective for low vision?
Research has shown that telerehabilitation, which participants in this trial may receive, can effectively help people with low vision improve their sight. One study found that using video calls for care worked just as well as visiting the office for training with magnifying tools. Other studies have demonstrated that it can help people read better and faster, making it a good alternative to traditional in-person sessions. This method allows people to receive care without traveling, which is especially helpful for those living far from clinics. Overall, telerehabilitation is a promising option for maintaining daily visual tasks.13678
Who Is on the Research Team?
Ava K Bittner, OD, PhD
Principal Investigator
University of California, Los Angeles
Are You a Good Fit for This Trial?
This trial is for adults over 18 with any level of vision loss from ocular disease, who've just received new magnification devices or visual assistive apps. It's not for those with conflicting schedules, substance abuse issues, severe hearing loss, major health conditions limiting participation or lifespan, communication difficulties regarding visual stimuli, need other low vision training, or have incompatible device features.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive low vision rehabilitation through either in-office care or telerehabilitation using magnification devices and visual assistive mobile apps
Follow-up
Participants are monitored for adherence to device use and satisfaction with rehabilitation services
What Are the Treatments Tested in This Trial?
Interventions
- Low Vision Rehabilitation
Low Vision Rehabilitation is already approved in United States, European Union, Canada for the following indications:
- Low vision due to various causes including age-related macular degeneration, diabetic retinopathy, glaucoma, and other conditions leading to visual impairment
- Visual impairment due to various ophthalmological conditions, including but not limited to macular degeneration, diabetic retinopathy, and glaucoma
- Low vision resulting from conditions such as age-related macular degeneration, diabetic retinopathy, and other causes of visual impairment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Southern California College of Optometry at Marshall B. Ketchum University
Collaborator
University of Nebraska
Collaborator
New England College of Optometry
Collaborator
Mid-Michigan Eye Care
Collaborator